Article ; Online: Prophylaxis, diagnosis and therapy of infections in patients undergoing high-dose chemotherapy and autologous haematopoietic stem cell transplantation. 2020 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).
2020 Volume 100, Issue 2, Page(s) 321–336
Abstract: To ensure the safety of high-dose chemotherapy and autologous stem cell transplantation (HDC/ASCT ... evidence-based recommendations on infectious complications after HDC/ASCT are given. This guideline not ... patients with solid tumours or autoimmune disorders. In addition to HBV and HCV, HEV screening is nowadays ...
| Abstract | To ensure the safety of high-dose chemotherapy and autologous stem cell transplantation (HDC/ASCT), evidence-based recommendations on infectious complications after HDC/ASCT are given. This guideline not only focuses on patients with haematological malignancies but also addresses the specifics of HDC/ASCT patients with solid tumours or autoimmune disorders. In addition to HBV and HCV, HEV screening is nowadays mandatory prior to ASCT. For patients with HBs antigen and/or anti-HBc antibody positivity, HBV nucleic acid testing is strongly recommended for 6 months after HDC/ASCT or for the duration of a respective maintenance therapy. Prevention of VZV reactivation by vaccination is strongly recommended. Cotrimoxazole for the prevention of Pneumocystis jirovecii is supported. Invasive fungal diseases are less frequent after HDC/ASCT, therefore, primary systemic antifungal prophylaxis is not recommended. Data do not support a benefit of protective room ventilation e.g. HEPA filtration. Thus, AGIHO only supports this technique with marginal strength. Fluoroquinolone prophylaxis is recommended to prevent bacterial infections, although a survival advantage has not been demonstrated. |
|||||
|---|---|---|---|---|---|---|
| MeSH term(s) | Germany ; Hematologic Neoplasms/therapy ; Hematology ; Hematopoietic Stem Cell Transplantation ; Hepacivirus/metabolism ; Hepatitis B/blood ; Hepatitis B/prevention & control ; Hepatitis B Antibodies/blood ; Hepatitis B virus/metabolism ; Hepatitis C/blood ; Hepatitis C/prevention & control ; Humans ; Medical Oncology ; Pneumocystis carinii/metabolism ; Pneumonia, Pneumocystis/blood ; Pneumonia, Pneumocystis/prevention & control ; Practice Guidelines as Topic ; RNA, Viral/blood ; Societies, Medical ; Transplantation, Autologous ; Trimethoprim, Sulfamethoxazole Drug Combination/therapeutic use | |||||
| Chemical Substances | Hepatitis B Antibodies ; RNA, Viral ; Trimethoprim, Sulfamethoxazole Drug Combination (8064-90-2) | |||||
| Keywords | covid19 | |||||
| Language | English | |||||
| Publishing date | 2020-10-20 | |||||
| Publishing country | Germany | |||||
| Document type | Journal Article ; Review | |||||
| ZDB-ID | 1064950-5 | |||||
| ISSN | 1432-0584 ; 0939-5555 ; 0945-8077 | |||||
| ISSN (online) | 1432-0584 | |||||
| ISSN | 0939-5555 ; 0945-8077 | |||||
| DOI | 10.1007/s00277-020-04297-8 | |||||
| Shelf mark |
|
|||||
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Uh III Zs.181: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.